# Bioequivalence Study of Sodium Valproate and Valproic Acid Tablets

> **NCT05641649** · PHASE4 · UNKNOWN · sponsor: **Kathmandu University** · enrollment: 16 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Sodium valproate and valproic acid extended release tablet

## Key facts

- **NCT ID:** NCT05641649
- **Lead sponsor:** Kathmandu University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-06
- **Primary completion:** 2023-10-13
- **Final completion:** 2023-11-30
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2023-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05641649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05641649, "Bioequivalence Study of Sodium Valproate and Valproic Acid Tablets". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05641649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*